DexCom, Inc.
DXCM
$72.70
-$5.14-6.60%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.64% | 1.97% | 15.26% | 24.21% | 26.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.64% | 1.97% | 15.26% | 24.21% | 26.90% |
| Cost of Revenue | 21.12% | 13.85% | 16.22% | 28.76% | 37.97% |
| Gross Profit | -0.12% | -4.73% | 14.70% | 21.47% | 21.30% |
| SG&A Expenses | 7.84% | 6.98% | 11.27% | 7.73% | -0.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.09% | 9.45% | 13.87% | 18.09% | 18.53% |
| Operating Income | -12.91% | -26.03% | 23.34% | 114.19% | 72.97% |
| Income Before Tax | -14.18% | -26.21% | 17.89% | 105.43% | 84.83% |
| Income Tax Expenses | 690.10% | -64.24% | 2.07% | -187.42% | -124.40% |
| Earnings from Continuing Operations | -40.81% | 11.52% | 23.81% | 201.23% | 179.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.81% | 11.52% | 23.81% | 201.23% | 179.19% |
| EBIT | -12.91% | -26.03% | 23.34% | 114.19% | 72.97% |
| EBITDA | -8.43% | -18.29% | 22.29% | 72.97% | 66.60% |
| EPS Basic | -41.80% | 9.39% | 19.95% | 198.49% | 180.85% |
| Normalized Basic EPS | -15.60% | -27.61% | 14.17% | 103.65% | 86.15% |
| EPS Diluted | -39.07% | 15.67% | 26.60% | 198.58% | 180.98% |
| Normalized Diluted EPS | -12.24% | -23.21% | 22.06% | 106.33% | 89.55% |
| Average Basic Shares Outstanding | 1.69% | 1.97% | 3.23% | 0.91% | -0.57% |
| Average Diluted Shares Outstanding | -2.21% | -3.89% | -3.41% | -0.43% | -2.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
